NCT07390487Recruiting
The Effects of Audio-Based Therapy on Anxiety in Psoriasis
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Brief summary (registry, in English)
Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxiety disorders up to 16%. Many experts recommend routine screening, referral, and interventions for anxiety in psoriasis; however, many barriers inhibit access to mental health resources and proper management. To our knowledge, there is a lack of easily accessible interventions that manage anxiety. Audio-based therapy offers convenient and effective interventions that show reduced anxiety in published, randomized studies and is a promising management for psoriasis patients. This study will evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 29 Jan 2026
- Start date
- Feb 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- University of California, San Francisco
- Diseases
- Psoriasis
- NCT number
- NCT07390487
What you commit to
- Study type: Interventional
- Planned participants: 120
- From Feb 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe hearing impairment precluding headphone listening
- Any condition requiring strict sound avoidance (such as seizure/epilepsy, major head trauma, severe sound-triggered migraine) that would make participation unsafe.
Other
- Other diagnoses that in the investigator's judgment preclude safe participation or interfere with anxiety or psoriasis evaluation.
Who the study is looking for
- Age ≥18 years
- Self-reported dermatologist-diagnosed psoriasis
- GAD 2-Item Score ≥1 at screening
- Ability to consent and complete pre- and post-intervention surveys.
- Internet access and the ability to use a computer/smartphone with headphones for a single 23-30 minute session at home.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Liao Lab at UCSF Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.